<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Structural MRI | Eloi Navet</title><link>https://eloinavet.github.io/en/tags/structural-mri/</link><atom:link href="https://eloinavet.github.io/en/tags/structural-mri/index.xml" rel="self" type="application/rss+xml"/><description>Structural MRI</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Thu, 01 Jan 2026 00:00:00 +0000</lastBuildDate><image><url>https://eloinavet.github.io/media/icon_hu_8f6568e474c94b92.png</url><title>Structural MRI</title><link>https://eloinavet.github.io/en/tags/structural-mri/</link></image><item><title>AI-Based Differential Diagnosis of Neurodegenerative Diseases Using Structural MRI: A Systematic Review</title><link>https://eloinavet.github.io/en/publication/2026-ai-based-differential-diagnosi-d1gkvwhdpl0c/</link><pubDate>Thu, 01 Jan 2026 00:00:00 +0000</pubDate><guid>https://eloinavet.github.io/en/publication/2026-ai-based-differential-diagnosi-d1gkvwhdpl0c/</guid><description>&lt;h2 id="abstract"&gt;Abstract&lt;/h2&gt;
&lt;p&gt;Accurate differential diagnosis among neurodegenerative diseases is a major clinical challenge due to overlapping symptomatology and pathologies. Artificial intelligence (AI) applied to structural MRI (sMRI) offers a promising, noninvasive approach for identifying subtle, disease-specific patterns of brain atrophy. This systematic review evaluates the landscape of AI methods for this purpose, focusing on the differential diagnosis between neurodegenerative diseases while excluding isolated disease-versus-control comparisons. Following the PRISMA guidelines, we analyzed 82 studies published between January 2008 and December 2025. Our analysis reveals a distinct methodological evolution from classical machine learning (ML), which relies on handcrafted features, to end-to-end deep learning (DL) architectures that automatically learn representations directly from image data. While models often report high classification accuracy (typically exceeding 90% for binary tasks), accuracy ranges from 70% to 92% for standard 3-class tasks, and drops to 65% to 88% for broader multi-disease frameworks (≥ 4 classes) or out-of-domain evaluations. Furthermore, we identify systemic barriers that delay clinical translation: a widespread reliance on private datasets (77% of studies), a severe lack of rigorous out-of-domain validation (only 28% of studies), a low rate of public code availability (20% of studies), and limited use of pathologically or biologically confirmed diagnostic labels (only 18% of studies). These challenges in data infrastructure and validation standards undermine model generalizability and cast doubt on the clinical relevance of …&lt;/p&gt;
&lt;h2 id="links"&gt;Links&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id="citation"&gt;Citation&lt;/h2&gt;
&lt;div class="hb-citation-display"&gt;Éloi Navet, Rémi Giraud, Boris Mansencal, Andrew Zamai, Vincent Planche, &amp;amp; Pierrick Coupé (2026). &lt;em&gt;AI-Based Differential Diagnosis of Neurodegenerative Diseases Using Structural MRI: A Systematic Review&lt;/em&gt;. d1gkVwhDpl0C. &lt;a href="https://hal.science/hal-05640352/" target="_blank" rel="noopener"&gt;https://hal.science/hal-05640352/&lt;/a&gt;&lt;/div&gt;
&lt;div class="js-cite-clipboard hb-citation-actions" data-filename="/citations/2026-ai-based-differential-diagnosi-d1gkVwhDpl0C.bib"&gt;
&lt;button class="button"&gt;Copy BibTeX&lt;/button&gt;
&lt;/div&gt;</description></item></channel></rss>